We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

129 hedge funds and large institutions have $749M invested in Exact Sciences in 2013 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 31 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

84% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 31

56% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 16

7% more funds holding

Funds holding: 121129 (+8)

7% less capital invested

Capital invested by funds: $808M → $749M (-$59M)

19% less call options, than puts

Call options by funds: $18.5M | Put options by funds: $22.8M

Holders
129
Holders Change
+8
Holders Change %
+6.61%
% of All Funds
4.18%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
25
Increased
57
Reduced
31
Closed
16
Calls
$18.5M
Puts
$22.8M
Net Calls
-$4.32M
Net Calls Change
+$637K
Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$55.2M -$277K -21,600 -0.5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$48.1M +$2.51M +195,830 +5%
GGHC
3
Gilder Gagnon Howe & Co
New York
$46M -$327K -25,508 -0.7%
WA
4
Wasatch Advisors
Utah
$43M -$1.92M -149,922 -4%
JP Morgan Chase
5
JP Morgan Chase
New York
$38.4M -$12.2M -949,877 -23%
First Trust Advisors
6
First Trust Advisors
Illinois
$32.8M +$35.7M +2,781,575 New
State Street
7
State Street
Massachusetts
$32.7M +$3.4M +265,015 +11%
Jennison Associates
8
Jennison Associates
New York
$29.5M +$1.17M +91,302 +4%
Goldman Sachs
9
Goldman Sachs
New York
$27.1M +$6.77M +527,640 +30%
BIT
10
BlackRock Institutional Trust
California
$25M +$1.87M +146,037 +7%
Luther King Capital Management (LKCM)
11
Luther King Capital Management (LKCM)
Texas
$23.8M -$165K -12,835 -0.6%
BFA
12
BlackRock Fund Advisors
California
$23.4M +$4.93M +384,288 +24%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$22.7M -$8.92M -695,404 -27%
CCI
14
Columbus Circle Investors
$22.2M +$16.5M +1,286,306 +215%
Invesco
15
Invesco
Georgia
$20.7M +$5.78M +450,266 +34%
PA
16
Perceptive Advisors
New York
$20.6M +$1.27M +98,756 +6%
Fidelity Investments
17
Fidelity Investments
Massachusetts
$18.8M +$10.7M +833,500 +110%
Loomis, Sayles & Company
18
Loomis, Sayles & Company
Massachusetts
$15.9M +$3.25M +253,488 +23%
TAM
19
Tiverton Asset Management
Delaware
$14.2M
Wells Fargo
20
Wells Fargo
California
$12.8M -$124K -9,635 -0.9%
Northern Trust
21
Northern Trust
Illinois
$11.8M +$848K +66,105 +7%
6CM
22
683 Capital Management
New York
$11.1M +$12.1M +940,000 New
ACH
23
ArrowMark Colorado Holdings
Colorado
$10.1M +$11M +855,720 New
JHIU
24
Janus Henderson Investors US
Colorado
$9.36M -$11M -854,949 -52%
Mackenzie Financial
25
Mackenzie Financial
Ontario, Canada
$9.35M +$1.48M +115,200 +17%

EXAS Hedge Fund Activity: Q3 2013 in Review

129 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2013, worth a combined $749M — down 7.3% from $808M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new EXAS positions and 16 closed out — a net gain of 9 holders — while 57 added to existing stakes and 31 trimmed.

The largest buyer was First Trust Advisors, opening a new position worth an estimated $35.7M. The largest seller was JP Morgan Chase, cutting an estimated $12.2M.

  • 129 institutional investors held Exact Sciences (EXAS) as of Q3 2013, up from 121 in Q2 2013.
  • Funds reported $749M of Exact Sciences stock for Q3 2013, down 7.3% quarter-over-quarter.
  • 25 funds opened new Exact Sciences positions in Q3 2013 and 16 closed out, a net change of +9 holders.
  • The largest Exact Sciences buyer in Q3 2013 was First Trust Advisors, an estimated $35.7M added.
  • The largest Exact Sciences seller in Q3 2013 was JP Morgan Chase, an estimated $12.2M sold.

Based on aggregated 13F filings for Q3 2013.